DMPHF (Dermapharm Holding SE) Cyclically Adjusted Book per Share: $7.69 (As of Mar. 2026)


DMPHF Dermapharm Holding SE DMPHF
83 GF Score
Price $53.00
GF Value $44.24
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Dermapharm Holding SE Cyclically Adjusted Book per Share?

Dermapharm Holding SE DMPHF 83 Cyclically Adjusted Book per Share is $7.69 as of Mar. 2026. GuruFocus rates DMPHF with a GF Score™ of 83/100 and a GF Value™ of $44.24 (Significantly Overvalued). The stock has 9 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Dermapharm Holding SE's adjusted book value per share for the three months ended in Mar. 2026 was $17.242. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $7.69 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-01), Dermapharm Holding SE's current stock price is $53.00. Dermapharm Holding SE's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $7.69. Dermapharm Holding SE's Cyclically Adjusted PB Ratio of today is 6.89.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Dermapharm Holding SE was 6.09. The lowest was 4.55. And the median was 5.43.


Dermapharm Holding SE  (OTCPK:DMPHF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Dermapharm Holding SE's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=53.00/7.69
=6.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Dermapharm Holding SE was 6.09. The lowest was 4.55. And the median was 5.43.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Dermapharm Holding SE Cyclically Adjusted Book per Share Related Terms


Dermapharm Holding SE Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Dermapharm Holding SE's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dermapharm Holding SE Cyclically Adjusted Book per Share Chart

Dermapharm Holding SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 7.88

Dermapharm Holding SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 7.88 7.69

DMPHF vs ZTS, UTHR, VTRS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dermapharm Holding SE Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Dermapharm Holding SE's Cyclically Adjusted PB Ratio falls into.


DMPHF
83GF Score
Dermapharm Holding SE DMPHF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dermapharm Holding SE Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dermapharm Holding SE's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=17.242/131.2583*131.2583
=17.242

Current CPI (Mar. 2026) = 131.2583.

Dermapharm Holding SE Quarterly Data

Book Value per Share CPI Adj_Book
201412 0.648 99.543 0.854
201512 0.832 99.717 1.095
201612 1.115 101.217 1.446
201703 0.000 101.417 0.000
201706 0.000 102.117 0.000
201709 1.538 102.717 1.965
201712 1.620 102.617 2.072
201803 4.582 102.917 5.844
201806 4.716 104.017 5.951
201809 5.203 104.718 6.522
201812 5.334 104.217 6.718
201903 5.748 104.217 7.239
201906 5.305 105.718 6.587
201909 5.318 106.018 6.584
201912 5.751 105.818 7.134
202003 6.261 105.718 7.774
202006 5.752 106.618 7.081
202009 6.503 105.818 8.066
202012 7.275 105.518 9.050
202103 7.923 107.518 9.672
202106 8.112 108.486 9.815
202109 9.247 109.435 11.091
202112 10.437 110.384 12.411
202203 10.925 113.968 12.582
202206 8.894 115.760 10.085
202209 9.266 118.818 10.236
202212 10.459 119.345 11.503
202303 11.545 122.402 12.380
202306 10.488 123.140 11.179
202309 10.821 124.195 11.436
202312 10.921 123.773 11.581
202403 11.748 125.038 12.332
202406 11.027 125.882 11.498
202409 12.033 126.198 12.516
202412 11.755 127.041 12.145
202503 12.822 127.779 13.171
202506 13.030 128.412 13.319
202509 14.153 129.255 14.372
202512 15.102 129.361 15.324
202603 17.242 131.258 17.242

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $7.69 mean?
Dermapharm Holding SE (DMPHF) has a Cyclically Adjusted Book per Share of $7.69 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Dermapharm Holding SE and its competitors.
Is Dermapharm Holding SE's Cyclically Adjusted Book per Share too high?
Dermapharm Holding SE's current Cyclically Adjusted Book per Share is $7.69. Overall, Dermapharm Holding SE has a GF Score™ of 83/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dermapharm Holding SE's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Dermapharm Holding SE's Cyclically Adjusted Book per Share of $7.69 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Dermapharm Holding SE and its competitors. Dermapharm Holding SE's current Cyclically Adjusted Book per Share is $7.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dermapharm Holding SE stock overvalued right now?
Based on GuruFocus' analysis, Dermapharm Holding SE (DMPHF) is currently considered Significantly Overvalued. The stock's GF Value™ is $44.24, compared to a current price of $53.00 — trading 19.8% above its estimated fair value. The current Cyclically Adjusted Book per Share is $7.69. Dermapharm Holding SE's overall GF Score™ is 83/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Dermapharm Holding SE (DMPHF), the current Cyclically Adjusted Book per Share is $7.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dermapharm Holding SE (DMPHF) Overvalued in 2026?

Based on GuruFocus' analysis, Dermapharm Holding SE stock appears to be overvalued. The current stock price of $53.00 is trading 19.8% above its estimated GF Value™ of $44.24. GuruFocus considers Dermapharm Holding SE to be Significantly Overvalued.

Key valuation signals for DMPHF:

  • Cyclically Adjusted Book per Share: $7.69
  • GF Value™: $44.24 vs. price of $53.00 (19.8% above fair value)
  • GF Score™: 83/100 with 9 warning signs

No single metric tells the full story. See the DMPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dermapharm Holding SE Business Description

Other Exchanges 0A5J:UKDMPd:UKDMP:Germany
Address Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.
83GF Score

Get the complete analysis for DMPHF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$53.00
Price
$44.24
GF Value